Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA383071
Max Phase: Preclinical
Molecular Formula: C32H37F2NO5
Molecular Weight: 463.61
Molecule Type: Small molecule
Associated Items:
ID: ALA383071
Max Phase: Preclinical
Molecular Formula: C32H37F2NO5
Molecular Weight: 463.61
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H](CCN1CCC(CCOC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1ccccc1.O=C(O)C(=O)O
Standard InChI: InChI=1S/C30H35F2NO.C2H2O4/c1-23(25-5-3-2-4-6-25)15-19-33-20-16-24(17-21-33)18-22-34-30(26-7-11-28(31)12-8-26)27-9-13-29(32)14-10-27;3-1(4)2(5)6/h2-14,23-24,30H,15-22H2,1H3;(H,3,4)(H,5,6)/t23-;/m0./s1
Standard InChI Key: WOORERZMTSEMTL-BQAIUKQQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 463.61 | Molecular Weight (Monoisotopic): 463.2687 | AlogP: 7.37 | #Rotatable Bonds: 10 |
Polar Surface Area: 12.47 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 9.87 | CX LogP: 7.52 | CX LogD: 5.08 |
Aromatic Rings: 3 | Heavy Atoms: 34 | QED Weighted: 0.31 | Np Likeness Score: -0.65 |
1. Greiner E, Boos TL, Prisinzano TE, De Martino MG, Zeglis B, Dersch CM, Marcus J, Partilla JS, Rothman RB, Jacobson AE, Rice KC.. (2006) Design and synthesis of promiscuous high-affinity monoamine transporter ligands: unraveling transporter selectivity., 49 (5): [PMID:16509591] [10.1021/jm050766f] |
Source(1):